-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascentage Pharma Reports Strong Phase II Results for Lisaftoclax in BTK-Refractory CLL/SLL

Reuters·12/08/2025 13:02:08

Please log in to view news